biOasis Technologies Ord Shs BIOAF

RE:RE:RE:RE:Maybe I am wrong but

[Boomskid]

ROSIE2023 says, "Amazing that dr dr can get money in one hand for her pet but no money for her other pet"

 

Carina Biotech is a private company. There are venture-type investors with a stake in it. They get to see all the inside information and they have interests to protect. My guess is that they are releasing money and inviting new investors as the need arises and as they see fit. As long as Carina's projects are moving forward, there will be no shortage of money. The reason is simple. A private company with something important has the potential to be an immediate blockbuster IPO on NASDAQ.

 

Bioasis is a long ways from that. It was created as a public company in the beginning for the very reason that public companies are always created - to get funding from retail investors. That's what Carina will do except that a small number of individual investors, all insiders, will get to make all the big money. They alone took the original chances and they get to benefit from them. Investors like Bioasis shareholders can't get close to deal like Carina (or Denali) until it's too late to make a big win.

 

Bioasis started with nothing. As a public company with broad ownership that large investors cannot control, and with all the rules associated with public companies, Bioasis does not have the same advantages. Money cannot be raised in large amounts from single investors. Control blocks are heavily discouraged by regulations.

 

Also, because Carina is a private company, there are no disclosure requirements. What news they do release is probably part of the set up for going public at some point. Some private companies issue no news. I would suggest that Carina is, at most, a year or two from going public, or being sold outright to a major pharma, if their pipeline works as hoped.

 

With respect the recent raise at Carina, there is no indication of who raised the money. Rathjen may not have been involved in that at all, or may have played a minor part in it. I'm sure she'll take as much credit as she can but the insiders will know how it went down.

 

There's another interesting little thing about Carina. If you haven't already noticed, you'll discover that Dr. Jose Iglesias MD is a part of Carina management. He's head of Carina's Medical Advisory Board.

 

On December 4, 2019, Dr. Iglesias was appointed consultant Chief Medical Officer and chair of the Medical Oncology Advisory Board at Bioasis. He left Bioasis shortly after these appointments because of a position he accepted elsewhere. I don't know or care whether that position was with Carina., but that's where he is now.

 

jd